Media Coverage

The vaccine, developed by an Israeli researcher at TAU, has already been shown to be effective in mice - both as preventative therapy and as a cure for active disease (Channel 12 News, 1.10.2019)

Israeli research that can lead to colon cancer prevention (Channel 11 News, 24.9.2019)

Thus far the vaccine has been proven effective in mice in preventing the development of melanoma and in treating primary tumors and metastases that result from the disease (ISREAL HAYOM 6.8.2019)

Researchers discover that fat cells play key role in deadly skin cancer transformation and have come up with a way to block process (ISREAL21c 24.7.2019) Also posted in the Jerusalem Post >>

New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows (THE TIMES OF ISRAEL, 2.6.2019)

Cells express surface markers that help them escape most targeted therapies, TAU researchers say (TAU AMERICAN FRIENDS, 12.3.2019ׁׁ)

Eosinophils -disease-fighting white blood cells,  known to cause allergies and asthma might help kill cancer cells (Haaretz, 23.01.2019)


Tel Aviv University researchers say cancer-fighting skills of eosinophils, the white blood cells that are responsible for allergies, could pave way to new drugs (THE TIMES OF ISRAEL, 23.1.2019ׁׁ)


Dr.  Dinorah Friedmann-Morvinski a senior scientist at Tel Aviv University studies glioblastoma (brain tumors) using  mouse models that mimic the disease in humans (Ynet, 03.1.2019)


New TAU Translational Medicine Center aims to develop pharmaceuticals better, faster and for less money (The Jerusalem Post, 29.4.2018)

The translational medicine center is aimed at providing professional guidance for drugs developed by the university and hospitals (GLOBES, 30.1.2018)

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive